GlaxoSmithKline PLC

GlaxoSmithKline PLC

GlaxoSmithKline PLC is a global healthcare company based in Brentford, London, in the United Kingdom. The company engages in the creation, discovery, development, manufacturing, and marketing of vaccines, over-the-counter medicines and health-related consumer products worldwide. It operates through three segments, namely pharmaceuticals (developing new medicines in respiratory, HIV, oncology and immuno-inflammation), vaccines (delivering over two million vaccine doses per day to people in more than 160 countries) and consumer healthcare (developing and marketing consumer healthcare products).

GlaxoSmithKline PLC was established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, although its foundations can be traced back to 1715 with the opening of a London apothecary shop. The company employs more than 100,000 people worldwide.

GlaxoSmithKline PLC has a primary listing on the London Stock Exchange (LSE). It is also listed on the New York Stock Exchange (NYSE). It is a constituent of the FTSE 100 index, comprising of 100 companies on the LSE with the biggest market capitalisation.

GlaxoSmithKline PLC Market Influences

GlaxoSmithKline PLC’s share price is influenced by a range of different factor, including governmental policy relating to the development and commercialisation of pharmaceuticals, economic policy and the general economic outlook, the industry’s performance and internal developments within the company.